Advertisement
Screener

PAVmed Inc. (PAVM) Business Acquisition, Pro Forma Net Income (Loss)

1.8 / 5 stars · 20/56 Roast Me

PAVmed Inc. Business Acquisition, Pro Forma Net Income (Loss)

PAVmed Inc. (PAVM) reported Business Acquisition, Pro Forma Net Income (Loss) of -$17.13 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.

Discontinued › Expense Statement › Operating Expenses

us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2022-05-16

  • PAVmed Inc. business acquisition, pro forma net income (loss) for the quarter ending 2022-03-31 was -$17.13M.
  • PAVmed Inc. business acquisition, pro forma net income (loss) for the quarter ending 2021-03-31 was -$9.51M.
Period endBusiness Acquisition, Pro Forma Net Income (Loss) 3 month
2022-03-31-$17.13M
10-Q · filed 2022-05-16
2021-03-31-$9.51M
10-Q · filed 2022-05-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
InspireMD, Inc. (NSPR)$0.033B
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
NEPHROS INC (NEPH)United States$0.046B23.02
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14